Dr. Ryan Noble Broderick

DMD | Dentist



  
  9135 Schaefer Rd, Ste 3, Converse
  Texas, 78109-1979

  210-607-8232    Maps & Directions
Dr. Ryan Noble Broderick is a Converse, Texas based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 9135 Schaefer Rd, Ste 3, Converse. Patients can reach him at 210-607-8232.
Dr. Ryan Noble Broderick is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Ryan Noble Broderick speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Ryan Noble Broderick
Specialization: Dentist
Gender:Male
Credentials: DMD
Accepts Medicare Assignment:May Accept
Practice Address:9135 Schaefer Rd, Ste 3, Converse,
Texas, 78109-1979
Phone:210-607-8232
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 7214233113
Enrollment ID: I20160302001354
NPI Number: 1003294406
NPI Enumeration Date: 18 May, 2015
NPI Last Update On: 18 May, 2015

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 9135 Schaefer Rd, Ste 3
Converse, Texas
Zip: 78109-1979
Phone Number: 210-607-8232
Patients can reach Dr. Ryan Noble Broderick at 9135 Schaefer Rd, Ste 3, Converse, Texas or can call to book an appointment on 210-607-8232. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: